| نویسندگان | پروانه محمدخانی-کیت دابسون-محمد رضا تمنائی فر-ایمانه عباسی-هدیه آزادمهر |
| تاریخ انتشار | 2016-9-01 |
| رتبه نشریه | علمی - پژوهشی |
| نوع نشریه | الکترونیکی |
| نمایه نشریه | ISC ,SID |
چکیده مقاله
Objective: Sexual dysfunction is frequently reported as a side effect of many antidepressant
medications. As a result, for those depressed patients to whom sexual desire is important,
psychological treatment may be a better intervention. Thus, the present study aimed to determine
the possible changes in sexual desire following psychological treatments in depression, when
focus of therapy is not on sexual function.
Methods: This is a quasi-experimental study, which was conducted in Tehran, Iran. A total of 281
depressed patients in the remission phase underwent psychological treatments, either cognitive
behavioral therapy (CBT, n=131) or mindfulness-based cognitive therapy (MBCT, n=150). The
therapy did not focus on any aspect of sexual function. Using a single item measure before
and after treatment, sexual desire of the patients was categorized into intact, mild, moderate, or
severe decline. A total of 255 participants completed the study questionnaires and were randomly
assigned to CBT (122) and MBCT groups (133). Before therapy, 128(50.2%) participants were
categorized in intact sexual desire group, 73(28.6%) in mild sexual desire dysfunction group,
40(15.7%) in moderate sexual desire dysfunction group, and 14(5.5%) in severe sexual desire
dysfunction group. Logistic regression was used for analyzing the data by SPSS-16.
Results: Low sexual desire in depression remission was predicted by age (P<0.001, OR=0.21,
CI=0.01–0.03), presence of comorbid anxiety disorder (P<0.04, OR=-0.13, CI=-0.46–0.02),
and global assessment of functioning (GAF) (P<0.001, OR=-0.23, CI=-0.03–0.01). Clinical
improvement in sexual desire was predicted by the type of intervention (P=0.023, OR=0.351,
CI=0.142–0.869) and GAF (P=0.003, OR=0.927, CI=0.881–0.975).
Conclusion: CBT might be superior to MBCT in improving sexual desire in patients with
depression. Further studies using validated sexual function questionnaires are necessary.